Evidence map›Paper›PMID 37766339›Full record

ArticleViruses2023

Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).

Andreas C Chrysostomou, Bram Vrancken, Christos Haralambous, Maria Alexandrou, Ioanna Gregoriou, Marios Ioannides, Costakis Ioannou, Olga Kalakouta, Christos Karagiannis, Markella Marcou and 11 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Andreas C ChrysostomouDepartment of Biological Sciences, University of Cyprus, Aglantzia, 2109 Nicosia, Cyprus.ORCID 0000-0002-5796-1588
Bram VranckenDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-6547-5283
Christos HaralambousUnit for Surveillance and Control of Communicable Diseases, Ministry of Health, 1148 Nicosia, Cyprus.
Maria AlexandrouMicrobiology Department, Larnaca General Hospital, 6301 Larnaca, Cyprus.
Ioanna GregoriouUnit for Surveillance and Control of Communicable Diseases, Ministry of Health, 1148 Nicosia, Cyprus.
Marios IoannidesMedicover Genetics, 2409 Nicosia, Cyprus.
Costakis IoannouMedical Laboratory of Ammochostos General Hospital, Ammochostos General Hospital, 5310 Paralimni, Cyprus.
Olga KalakoutaUnit for Surveillance and Control of Communicable Diseases, Ministry of Health, 1148 Nicosia, Cyprus.
Christos KaragiannisMicrobiology Department, Nicosia General Hospital, 2029 Nicosia, Cyprus.
Markella MarcouDepartment of Microbiology, Archbishop Makarios III Hospital, 2012 Nicosia, Cyprus.
Christina MasiaMedical Laboratory of Ammochostos General Hospital, Ammochostos General Hospital, 5310 Paralimni, Cyprus.
Michail MendrisMicrobiology Department, Limassol General Hospital, 4131 Limassol, Cyprus.
Panagiotis PapastergiouMicrobiology Department, Limassol General Hospital, 4131 Limassol, Cyprus.
Philippos C PatsalisMedicover Genetics, 2409 Nicosia, Cyprus.
Despo PieridouMicrobiology Department, Nicosia General Hospital, 2029 Nicosia, Cyprus.
Christos ShammasS.C.I.N.A. Bioanalysis Sciomedical Centre Ltd., 4040 Limassol, Cyprus.
Dora C StylianouDepartment of Biological Sciences, University of Cyprus, Aglantzia, 2109 Nicosia, Cyprus.
Barbara ZinieriMicrobiology Department, Paphos General Hospital, Achepans, 8026 Paphos, Cyprus.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
The Comessar Network
Leondios G KostrikisDepartment of Biological Sciences, University of Cyprus, Aglantzia, 2109 Nicosia, Cyprus.ORCID 0000-0002-5340-7109
University of Cyprus · CYLimassol General Hospital · CYMinistry of Health · CYPaphos General Hospital · CYNicosia General Hospital · CYArchbishop Makarios III Hospital · CYLarnaca College · CYMedicover · DERega Institute for Medical Research · BEUniversité Libre de Bruxelles · BEUniversity of Nicosia · CY

Funding

European Research Council ERC (grant no.725422-ReservoirDOCS), EU grant 874850 MOOD, Research Foundation-Flanders ('Fonds voor Wetenschappelijk Onderzoek-Vlaanderen', G066215N, G0D5117N and G0B9317N), awarded to Philippe Lemey
6 · The paper itself

Abstract

Commencing in December 2019 with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), three years of the coronavirus disease 2019 (COVID-19) pandemic have transpired. The virus has consistently demonstrated a tendency for evolutionary adaptation, resulting in mutations that impact both immune evasion and transmissibility. This ongoing process has led to successive waves of infections. This study offers a comprehensive assessment spanning genetic, phylogenetic, phylodynamic, and phylogeographic dimensions, focused on the trajectory of the SARS-CoV-2 epidemic in Cyprus. Based on a dataset comprising 4700 viral genomic sequences obtained from affected individuals between October 2021 and October 2022, our analysis is presented. Over this timeframe, a total of 167 distinct lineages and sublineages emerged, including variants such as Delta and Omicron (1, 2, and 5). Notably, during the fifth wave of infections, Omicron subvariants 1 and 2 gained prominence, followed by the ascendancy of Omicron 5 in the subsequent sixth wave. Additionally, during the fifth wave (December 2021-January 2022), a unique set of Delta sequences with genetic mutations associated with Omicron variant 1, dubbed "Deltacron", was identified. The emergence of this phenomenon initially evoked skepticism, characterized by concerns primarily centered around contamination or coinfection as plausible etiological contributors. These hypotheses were predominantly disseminated through unsubstantiated assertions within the realms of social and mass media, lacking concurrent scientific evidence to validate their claims. Nevertheless, the exhaustive molecular analyses presented in this study have demonstrated that such occurrences would likely lead to a frameshift mutation-a genetic aberration conspicuously absent in our provided sequences. This substantiates the accuracy of our initial assertion while refuting contamination or coinfection as potential etiologies. Comparable observations on a global scale dispelled doubt, eventually leading to the recognition of Delta-Omicron variants by the scientific community and their subsequent monitoring by the World Health Organization (WHO). As our investigation delved deeper into the intricate dynamics of the SARS-CoV-2 epidemic in Cyprus, a discernible pattern emerged, highlighting the major role of international connections in shaping the virus's local trajectory. Notably, the United States and the United Kingdom were the central conduits governing the entry and exit of the virus to and from Cyprus. Moreover, notable migratory routes included nations such as Greece, South Korea, France, Germany, Brazil, Spain, Australia, Denmark, Sweden, and Italy. These empirical findings underscore that the spread of SARS-CoV-2 within Cyprus was markedly influenced by the influx of new, highly transmissible variants, triggering successive waves of infection. This investigation elucidates the emergence of new waves of infection subsequent to the advent of highly contagious and transmissible viral variants, notably characterized by an abundance of mutations localized within the spike protein. Notably, this discovery decisively contradicts the hitherto hypothesis of seasonal fluctuations in the virus's epidemiological dynamics. This study emphasizes the importance of meticulously examining molecular genetics alongside virus migration patterns within a specific region. Past experiences also emphasize the substantial evolutionary potential of viruses such as SARS-CoV-2, underscoring the need for sustained vigilance. However, as the pandemic's dynamics continue to evolve, a balanced approach between caution and resilience becomes paramount. This ethos encourages an approach founded on informed prudence and self-preservation, guided by public health authorities, rather than enduring apprehension. Such an approach empowers societies to adapt and progress, fostering a poised confidence rooted in well-founded adaptation.

Indexed as

CoinfectionCOVID-19CyprusGenomicsHumansPandemicsPhylogenySARS-CoV-2COVID-19Cyprusgenomic epidemiologySARS-CoV-2

Identifiers

PMID37766339
PMCPMC10535466
OpenAlexW4386814600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.